Malcolm Gladwell

I was going to say eyes. Eyes, yeah. I was reading a really fascinating study that was looking, trying to figure out what the difference is between a novice police officer and an expert police officer. And they used eye tracking, gave them scenarios, and figured out that they're looking at different things. So you have a...

I was going to say eyes. Eyes, yeah. I was reading a really fascinating study that was looking, trying to figure out what the difference is between a novice police officer and an expert police officer. And they used eye tracking, gave them scenarios, and figured out that they're looking at different things. So you have a...

scenario of like that guy here and this happening here and someone throwing this here and we see the experts like looking and the novices looking Right? Yeah. One spot versus, but I'm just curious about like, you know, my sense is this is kind of, once you start going down this road.

scenario of like that guy here and this happening here and someone throwing this here and we see the experts like looking and the novices looking Right? Yeah. One spot versus, but I'm just curious about like, you know, my sense is this is kind of, once you start going down this road.

Yeah. Yeah. Why? One of the things you said earlier piqued my interest when you said that if you're making drugs and the question, one of the questions that comes up is, are you using something like this, a wearable, to market the drug? But I'm wondering whether that's... There's another way to frame that is...

Yeah. Yeah. Why? One of the things you said earlier piqued my interest when you said that if you're making drugs and the question, one of the questions that comes up is, are you using something like this, a wearable, to market the drug? But I'm wondering whether that's... There's another way to frame that is...

Surely one logical step here is that you start to, you're not just giving someone a drug, you're giving someone a drug in combination with a set of wearables that allow us to maximize the value of the drug. therapeutic, right?

Surely one logical step here is that you start to, you're not just giving someone a drug, you're giving someone a drug in combination with a set of wearables that allow us to maximize the value of the drug. therapeutic, right?

Is that what we're, are we going to be, are we going to be, are you going to be getting from your pharmacist or your doctor a package of things to take home along with your medication?

Is that what we're, are we going to be, are we going to be, are you going to be getting from your pharmacist or your doctor a package of things to take home along with your medication?

Yeah. Who controls this data? So interesting, you began this conversation in talking about the multitude of steps that exist between the manufacturer of some of these medicines and the user. That's right. Now you're talking about a system where presumably the manufacturer can speak directly to the patient.

Yeah. Who controls this data? So interesting, you began this conversation in talking about the multitude of steps that exist between the manufacturer of some of these medicines and the user. That's right. Now you're talking about a system where presumably the manufacturer can speak directly to the patient.

Does this mean that you cut out some of the middlemen?

Does this mean that you cut out some of the middlemen?

My mom... is in a nursing home has arthritis yeah which acts up on and so she moves around a lot this is a perfect tool for her so somebody is so does she is the model here that she checks her movement scores and that's a way of and she can choose she can see oh this is time to share that my data with a practitioner isn't it more efficient for her to have someone who is

My mom... is in a nursing home has arthritis yeah which acts up on and so she moves around a lot this is a perfect tool for her so somebody is so does she is the model here that she checks her movement scores and that's a way of and she can choose she can see oh this is time to share that my data with a practitioner isn't it more efficient for her to have someone who is

or AI or something that's continuously monitoring her?

or AI or something that's continuously monitoring her?

But we're moving. What's interesting, a lot of these things, the implication of what you're talking about is we are moving the primary point of contact from the hospital or the doctor's office to the home. Correct.

But we're moving. What's interesting, a lot of these things, the implication of what you're talking about is we are moving the primary point of contact from the hospital or the doctor's office to the home. Correct.